# The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle

> **NCT00614406** · NA · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 11 (actual)

## Conditions studied

- Ovulation (Follicular Rupture Yes/no)
- Menstrual Cycles (Total Length, Bleeding Days)
- Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)

## Interventions

- **DRUG:** Celebrex
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00614406
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2012-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614406, "The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00614406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*